Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Addiction in DSM-5 (June/July) | 2013

View Archived Issues

DSM-5: Clinical and Financial Implications

June 1, 2013

The new DSM-5 will change the way clinicians diagnose substance use disorders (SUD) and could have far-reaching consequences for patients seeking treatment and clinicians and organizations offering that treatment. Read More

Addiction Through the Decades: From DSM-I to DSM-5

June 1, 2013

Addiction has been around seemingly forever. However, how we have conceptualized it, has changed considerably over time. Read More

Substance Use Disorder in DSM-5

June 1, 2013

Learn the motivation and reasoning behind the substance use disorders section of DSM-5 in this interview with chair of the substance use disorders workgroup, Charles P O’Brien, MD, PhD Read More

CBT Doesn’t Improve Effectiveness of Office-Based Buprenorphine Treatment

June 1, 2013

The ability of primary care and other office-based physicians to prescribe buprenorphine has more than doubled the capacity of the US healthcare system to treat patients addicted to prescription opioids and heroin. One barrier to expanding access to this treatment is that some physicians cite a lack of available counseling services as reason not to offer buprenorphine treatment in their offices. Read More